Optipharm.CO.LTD (153710) — Capital Reinvestment Ratio
Optipharm.CO.LTD (153710) has a Capital Reinvestment Ratio of 0.14x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩905.29 Million) in capital expenditures (₩130.67 Million). Check Optipharm.CO.LTD tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Optipharm.CO.LTD Capital Reinvestment Ratio (2016–2019)
This chart tracks Optipharm.CO.LTD's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Optipharm.CO.LTD cash conversion from operations.
Annual Capital Reinvestment Ratio for Optipharm.CO.LTD (2016–2019)
Year-by-year Capital Reinvestment Ratio for Optipharm.CO.LTD from 2016 to 2019. See Optipharm.CO.LTD (153710) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.40x | ₩447.47 Million | ₩626.46 Million | ▲ +730.3% |
| 2018 | 0.17x | ₩1.20 Billion | ₩202.91 Million | ▼ -93.4% |
| 2017 | 2.57x | ₩260.86 Million | ₩670.33 Million | ▲ +464.7% |
| 2016 | 0.46x | ₩861.36 Million | ₩391.95 Million | — |